Academic Journal

Development of a Highly Efficient CRISPR/Cas9-Mediated Herpesvirus of Turkey-Based Vaccine against Novel Variant Infectious Bursal Disease Virus

Λεπτομέρειες βιβλιογραφικής εγγραφής
Τίτλος: Development of a Highly Efficient CRISPR/Cas9-Mediated Herpesvirus of Turkey-Based Vaccine against Novel Variant Infectious Bursal Disease Virus
Συγγραφείς: Jun-Feng Zhang, Jong-Yeol Park, Sang-Won Kim, Yu-Ri Choi, Se-Yeoun Cha, Hyung-Kwan Jang, Bai Wei, Min Kang
Πηγή: Vaccines, Vol 12, Iss 3, p 226 (2024)
Στοιχεία εκδότη: MDPI AG, 2024.
Έτος έκδοσης: 2024
Συλλογή: LCC:Medicine
Θεματικοί όροι: variant infectious bursal disease virus, recombinant vector vaccine, herpesvirus of turkeys, CRISPR/Cas9, Medicine
Περιγραφή: Infectious bursal disease (IBD), caused by IBD virus (IBDV), is an extremely contagious immunosuppressive disease that causes major losses for the poultry industry worldwide. Recently, the novel variant IBDV (G2d) has been highly prevalent in Korea, but the current vaccines against this very virulent IBDV have limited efficacy against this novel variant. To develop a vaccine against this variant IBDV, a recombinant virus designated rHVT-VP2 was constructed by inserting the IBDV (G2d) VP2 gene into herpesvirus of turkeys (HVT) using CRISPR/Cas9 gene-editing technology. The PCR and sequencing results obtained showed that the recombinant virus rHVT-VP2 was successfully constructed. Vaccination with rHVT-VP2 generated IBDV-specific antibodies in specific pathogen-free chickens starting from 2 weeks post-immunization. Seven days after the challenge, the autopsy results showed that the bursa atrophy rates of the rHVT-VP2, HVT, vaccine A, and positive control groups were 0%, 100%, 60%, and 100%, respectively, and the BBIX values were 1.07 ± 0.22, 0.27 ± 0.05, 0.64 ± 0.33, and 0.32 ± 0.06, respectively. These results indicate that rHVT-VP2 can provide 100% protection against a challenge with the IBDV (G2d), whereas vaccine A only provides partial protection. In conclusion, vaccination with the recombinant virus rHVT-VP2 can provide chickens with effective protection against variant IBDV (G2d).
Τύπος εγγράφου: article
Περιγραφή αρχείου: electronic resource
Γλώσσα: English
ISSN: 2076-393X
Relation: https://www.mdpi.com/2076-393X/12/3/226; https://doaj.org/toc/2076-393X
DOI: 10.3390/vaccines12030226
Σύνδεσμος πρόσβασης: https://doaj.org/article/ca3c33ca1e5f4018af3cc4655cd3e800
Αριθμός Καταχώρησης: edsdoj.3c33ca1e5f4018af3cc4655cd3e800
Βάση Δεδομένων: Directory of Open Access Journals
Περιγραφή
ISSN:2076393X
DOI:10.3390/vaccines12030226